ENANTA PHARMACEUTICALS INC — Form 8-K
Filed October 28, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 72/100
What the filing says
Jay R. Luly, Ph.D., age 70, will retire as President and CEO effective February 1, 2027, after 23 years leading Enanta. He will serve as Strategic Advisor through 2027. Tara L. Kieffer, Ph.D., who joined Enanta in 2020 and most recently served as Chief Product Strategy Officer (after 16 years at Vertex), has been appointed Chief Operating Officer in a newly created role. The Board is conducting a comprehensive search for Luly's successor, considering internal and external candidates.
Why this rating
Leadership succession at clinical-stage biotech is material; 23-year CEO departure creates execution risk. Kieffer's COO promotion doesn't fill CEO vacuum. No successor named yet—uncertainty. Moderate offsetby orderly transition plan and strong pipeline.
Tradability signal
SHORT
conviction 37/100 · expected -0.51% over 4 hrs
SHORT (drift): bad news keeps sliding after dissemination — our one persistent measured edge. Similar past filings (60 in this cell) moved +0.72% in the called direction over 4 hrs; shrunk for sample size that's a +0.51% edge. Price is down 3.5% since the filing hit EDGAR — the slide has begun. Exit plan: HARD stop 7% against entry — 1.4× this stock's measured hourly volatility, fixed, not trailing (trails test terribly on these names) — time exit 4 hrs. (Filing arrived outside market hours — evaluated at the next open with a live quote.)
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it negative)
before filing · preread $11.99 ▲ 2.30% | at our read · unknown $11.72 | +10 min · unknown $11.50 ▼ 1.88% | +30 min · unknown $11.56 ▼ 1.37% | +1 hr · unknown $11.31 ▼ 3.46% | +4 hrs · unknown $11.58 ▼ 1.19% |
The stock had already moved -2.25% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.